Researchers at The University of Kansas Cancer Center are investigating a new treatment they designed and are manufacturing in-house to outsmart cancers that are resistant to a game-changing form of immunotherapy for various blood cancers.
Researchers at The University of Kansas Cancer Center are investigating a new treatment they designed and are manufacturing in-house to outsmart cancers that are resistant to a game-changing form of immunotherapy for various blood cancers.